I am a Senior Scientist at the UK Medicines and Healthcare products Regulatory Agency (MHRA), where I develop and characterise biological reference materials to support the quality, safety and consistency of advanced therapy medicinal products (ATMPs). My work focuses on addressing measurement and standardisation challenges across the cell therapy landscape, helping to enable reliable product development, manufacturing and regulatory assessment. I collaborate closely with industry, academic and regulatory partners to advance regulatory science and promote the adoption of robust analytical standards. My goal is to support innovation in advanced therapies while helping ensure patients receive high-quality, effective medicines.